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Ia antigens are highly polymorphic membrane glycoproteins coded for by loci in 
the I region of the murine H-2 major histocompatibility gene complex (MHC) 1. They 
are expressed predominantly on cells involved in the generation of immune responses, 
and considerable information is available on the genetics and structure of Ia antigens 
common to B lymphocytes and macrophages. One Ia complex is immunoprecipitated 
by alloantibodies to the 1-A subregion and consists of A~ and Aa polypeptide chains, 
both of which are products of loci in the I-A subregion (1-3). Antibodies prepared in 
I-E subregion incompatible strains precipitate a complex of E~ and A~ (Ea) polypeptide 
chains. Although the E~ chain is encoded by a locus in the 1-E subregion, the A~ chain 
is the product of a  third Ia locus in the 1-A subregion (4-6). Intracellular A,:Ap and 
A~:E~ complexes appear to associate with an additional polypeptide chain, the Ia- 
associated invariant chain (Ii) (7). This chain is nonpolymorphic (3, 7, 8) and appears 
not to be expressed on the cell surface (9);  at this time its significance is not known. 
In  addition  to  Ia  antigens  the  1  region  controls  functional  traits  involved  in  the 
induction and regulation of immune responses. Immune response (Ir)  and  immune 
suppression  (ls)  genes  regulate  the  stimulation  and  suppression,  respectively,  of 
immune responses.  The generation or suppression of specific immune responses to 
some antigens is under the dual control of loci in the 1-A and 1-E/C subregions (10). 
Due  to  the  similarities  in  the  genetics  of Ia  antigens  and  /-region-controlled 
functions and to the expression of Ia antigens on cells involved in immune functions, 
a direct role for Ia antigens in the induction and regulation of immune responses has 
been  postulated.  Within  the  last  several  years  evidence that  Ia  antigens  are  the 
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products  of lr  genes  has  accumulated  from  a  variety  of genetic,  functional,  and 
biochemical studies  (4,  11-13).  It  is  apparent  from these  and  other studies  that  T 
lymphocytes recognize nominal (foreign, non-MHC) antigens in the context of self Ia 
on antigen-presenting cells (APC)  (14).  Although the precise mechanism(s) by which 
Ia antigens mediate lr gene function  is not known,  factors that affect the structure 
and expression of Ia antigens on the surfaces of APC are certain to modulate immune 
response potential. 
Recent genetic and biochemical investigations have revealed that Ia antigens are 
an extremely diverse set of proteins. Variability in  Ia structure and expression has 
several sources. First, many mouse strains express two distinct complexes of Ia antigens 
on their cell membranes, A~:Ap and A~:E~. Second, all four Ia polypeptide chains are 
genetically  polymorphic  (1,  3,  15),  although  the  degree  and  complexity  of  the 
polymorphism varies from chain to chain. Third, some alleles at the loci controlling 
the Ae and E~ chains are not expressed, i.e., they behave as null or silent alleles (4,  16, 
17). Finally, additional molecular polymorphism arises from combinatorial association 
of Ia chains. Cells from I region heterozygotes can express mixed haplotype (hybrid) 
A~:Ap and A~:E~ complexes in addition to the parental forms (4,  16,  18);  as a  result, 
individual cells can express as many as eight different Ia complexes. 
All  of the  factors mentioned  above contribute  to  the  qualitative  diversity of Ia 
antigens  and thus  may affect immune response potential.  The studies  presented  in 
this  paper  describe  an  additional  and  novel  source  of variability  in  Ia  antigen 
expression, one that affects the quantitative levels of certain Ia antigens.  Serological 
and biochemical studies have revealed that cells from Fa heterozygotes between the u 
haplotype  and  the  b,  k,  and  s  haplotypes  have  much  lower  amounts  of A~'k~:E~ 
Ae.E~ complexes, apparently due to the preferential  complexes on their surfaces than  u.  u 
association of the two u-haplotype chains with each other. In the accompanying paper 
(19)  we  report  that  the  quantitative  deficiency  in  expression  of A~'S:E~  in  certain 
strains results in a corresponding defect in antigen presenting-cell function. Thus the 
ability of cells to carry out/-region-controlled functions is dependent on the quantity 
as well as the quality of Ia antigens expressed. 
Materials and Methods 
Mice.  B10, B10.D2,  and  B10.A(4R)  mice used  in  the  fluorescence-activated cell  sorter 
(FACS)  and  two-dimensional polyacrylamide gel  electrophoresis  (2-D  PAGE)  studies  were 
obtained from Dr. H. O. MeDevitt, Stanford University School of Medicine, Stanford, Calif. 
All other mice were bred in our animal facilities  at the National Institutes of Health, Yale 
University (New Haven, Conn.), and Stanford University. 
Antibodies.  The (B10.S(7R)  ×  A.CA)F1 anti-B10.HTT antiserum was generously provided 
by Dr. H. O. McDevitt. Monoclonal antibody Y-17, resulting from a BALB/c anti-B 10.A(5R) 
immunization, has been shown to react with specificity Ia.m44, a combinatorial or conforma- 
tional determinant on certain A~:E, Ia complexes (13). The hybridoma cell lines 14-4-4 and 17- 
3-3, producing monoclonal anti-Ia.7 and anti-A,:E~  antibodies, respectively (20), were gifts 
from Dr. Keiko Ozato and Dr. David Sachs of the National Cancer Institute. The hybridoma 
cell line MK-D6 producing an anti-I-A  a monoclonal antibody was generously provided by Dr. 
Philippa Marrack and Dr. John Kappler of the University of Colorado Medical School, Denver, 
Colo. The preparation and reactivities of the 10-2.16 and 10-3.6 monoclonal anti-I-A antibodies 
and of the 10-4.22 anti-Ig 5a(8) antibody have been previously described  (21). The anti-dansyl 
monoclonal antibody 27-4-4 was a  gift of Dr. Vernon T. Oi, Stanford University School  of 
Medicine. 
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previously (22). Briefly, 2,000 spleen cells were incubated with appropriately diluted antiserum 
for 15 min at 37°C, washed, and incubated with rabbit complement (1:12)  for 30 min at 37°C. 
The cells were then  stained with the vital dye nigrosin, and  the living and  dead cells were 
enumerated using an inverted microscope. 
Quantitative Absorption.  In vitro absorption analysis was performed by absorbing 50 ,ul of 
1:104 diluted Y-17 ascites fluid with graded numbers of  spleen cells for 1 h at room temperature. 
The number of cells required for complete absorption of antibody reactive with  B10.A(5R) 
spleen cells was determined in the dye exclusion microcytotoxic assay. 
Quantitative Immunofluorescence.  All monoclonal antibodies for these studies were purified from 
culture supernatant fluids on protein A Sepharose (Pharmacia Fine Chemicals, Piscataway, N. 
J.)  columns; conjugation of the purified antibodies with fluorescein isothiocyanate was per- 
formed according to the method of Goding (23). All reagents were centrifuged at 100,000 g for 
10 min before use. Spleen cells (1 ×  10  e') were stained directly by incubation at 4°C for 30 min 
with saturating levels of each fluorescein-conjugated monoclonal antibody. The stained cells 
were  analyzed  on  the  modified  FACS  II  (B-D  FACS  Systems,  Becton-Dickinson  &  Co., 
Sunnyvale, Calif.)  in  the  laboratory of Dr.  L.  A.  Herzenberg,  Dept.  of Genetics, Stanford 
University School of Medicine. This FACS II is equipped with a  logarithmic amplifier that 
shows the fluorescence intensity distribution over a  1-10' range. 
The calibration of the FACS system with free fluorescein, which allowed the quantitative 
measurements  to  be  made,  was  done  by  Dr.  D.  R.  Parks,  Stanford  University School  of 
Medicine.  For each  stained  sample,  10,000  cells were  analyzed,  and  the  geometric  mean 
fluorescence of the positive cells was calculated and converted to fluorescein equivalents (FE) 
as described by Ledbetter et  al.  (24).  The  mean  numbers  of antibody molecules bound  to 
positive cells were determined by the calculation 
mean FE of positive cells -  mean FE of unstained cells 
molar fluorescein/protein (F/P) ratio of conjugated antibody 
F/P ratios of the monoclonal antibodies used were:  I4-4-4, 5.3;  Y-17, 4.4;  17-3-3, 4.0;  10-3.6, 
5.1;  and MK-D6, 6.3.  The mean autofluorescence of unstained cells and the fluorescence of 
cells stained with  the control monoclonal antibody 27-4-4  (anti-dansyl) were  identical and 
equivalent to 7.7 X  10a-9.7  ×  10  a fluorescein molecules/cell. 
Biochemical Analysis ofla Antigens.  Labeling of mouse splenic lymphocytes with [35S]methio- 
nine, immunoprecipitation of Ia antigens, 2-D PAGE were done as previously published (7, 
25).  Immunoprecipitated  proteins  were  separated  by  charge  in  the  first  dimension  using 
nonequilibrium  pH  gradient electrophoresis, which  resolves proteins with  isoelectric points 
between pH 4.5  and 9.  The second dimension size separation was clone on  10%  acrylamide 
sodium  dodecyl sulfate  slab  gels.  Positions of the  separated  proteins  were  determined  by 
fluorography, using sodium salicylate as the fluorogenic compound and Kodak XAR-5 film 
(Eastman Kodak Co., Rochester, N. Y.). 
Results 
The studies presented below were prompted  by the unexpected  observation that 
cells from Fa mice produced by crossing the I-A k strain B10.A(4R)  with Ia.7 + strains 
present  the  antigen  pigeon  cytochrome c  to  primed  B10.A  T  cells for  proliferative 
responses, with the exception of Ia.7 + strains carrying the u haplotype (19).  Consid- 
erable evidence  now  exists that  Ae:Ea Ia complexes on  the  surface  of APC  are  in- 
volved in antigen presentation in this system (13, 26);  thus, it seemed likely that the 
inability of the u haplotype to function might be due to an absence or defect in the 
A~:E~ complex. Several approaches have been  used to examine this possibility. The 
first involved serological assays for the presence of Ia complexes with E~ chains on cell 
surfaces.  We  have  taken  advantage of the  availability of the  monoclonal  antibody 
Y-17,  which  reacts with  specificity Ia.m44  (13),  a  combinatorial or conformational 
determinant  on  certain  A~:E~ complexes.  Ia.m44  is expressed uniquely  on  the  two- McNICHOLAS ET AL.  493 
fAbS r, kd  Ak.E  k  andA~:E~  chain complex, not on either chain by itself; complexes o  e' :r~d  ,, ..... 
have been shown to express Ia.m44, while Ad:E~ and A~:E~ complexes do not (13). As 
w.~-  ,UEU  the data presented below will show, Y-17 does not react  ltn~:  ~ complexes but 
does react with complexes composed of  E~ and A~  'k'8 chains. Thus, Y-17 can be used 
to test serologically for the presence of complexes  .Ab k ~ ~u  or~e' ':r,~  in F1 hybrids carrying 
the u haplotype. 
Failure  to  Detect  A~'k'~:E~  Complexes  on  the  Cell  Surface  with  Y-17  by  Direct 
Cytotoxicity.  We have shown previously that Ab'S'l~k'a  k  k  r  r  .......  Ae:E~,  and A~:E~ complexes 
can be detected on lymphocyte surfaces with Y-17 by direct cytotoxic tests (13). Data 
b  p  k  d  k  p  v,  v  Ae. E~  can  in Table I  show that A~:E~, A~:E~, Ae:E~, A~:E~, and  complexes  also be 
detected by direct cytotoxicity. However, no significant lysis above background was 
observed  with  spleen  cells  from  (B10  X  B10.PL)F1  or  (B10  X  PL/J)Fx  (A~:E~), 
[B10.A(4R)  ×  B10.PL]F1 (A~:E~),  or  (B10.S  ×  B10.PL)F~ (A~:E~  mice. There are 
several possible explanations for the failure of Y-17 to kill cells from these hybrids. 
First,  Y-17  may not  react  with A~'k's:E u  complexes.  Second,  Y-17  may react  with 
A~'k's:E~ complexes but they may not be expressed on the surfaces of cells in the F1 
hybrids tested. Third, these complexes may be expressed and recognized by Y- 17 but 
may not cause lysis in the direct cytotoxic assay. Data in the following sections will 
show  that  the  third  alternative  is  correct, and  that  the  failure to  detect A~'k'~:E~ 
complexes with Y-17 by direct cytotoxicity is due to the low level of expression of 
these complexes. 
Detection  of Ab'k'8:E~  Complexes  with  Y-17  by  Quantitative  Absorption  Analysis.  To 
determine whether Ia.m44  is expressed, quantitative absorption analyses were per- 
formed; the results are shown in Fig.  1 and Table I. No discernible difference was 
observed in the capacity of cells from Ia.m44 + homozygous animals to absorb Y-17 
activity; comparative absorption ratios of 1.0-1.4 were obtained, using the number of 
BI0.A(5R) spleen cells required to absorb Y-17 activity as a standard.  Comparative 
absorption ratios for Ia.m44  + F1 hybrids expressing A~'k'~:E  d'k'p complexes range from 
1.2-3.3 with a  mean of 2.0.  Most important, u-haplotype heterozygotes were able to 
absorb Y-17 activity, although comparative absorption ratios for F1 hybrids carrying 
I-A b'~ and LE ~ subregions revealed seven- to eightfold less expression of the Ia.m44 
determinant  than  for  Ia.m44  +  homozygotes.  Reduced  expression  of Ia.m44  in  F1 
hybrids carrying the I-A k and I-E ~ subregions will be shown by quantitative immu- 
no  fluorescence analyses below. Since the Ia.m44 determinant recognized by Y-17 is 
uniquely expressed on Ae:E~  complexes  (13),  it  can  be concluded that  F1  hybrids 
carrying the I-A b'k'~ and I-E ~ subregions do express Ab'k'~:E] complexes on their cell 
surfaces.  However,  quantitatively  less  Ia.m44  antigen  is  expressed  compared  to 
homozygous mice or F1 mice not carrying the u haplotype; this low level of expression 
of Ia.m44 may be insufficient to promote direct lysis by Y- 17 and complement in the 
microcytotoxic assay. 
Quantitation  of A~:E~  Expression  on  Individual  Parental  and  F1  Cells  by  Quantitative 
Immunofluorescence.  The levels of cell surface A~:E,  complexes on spleen cells  from 
parental and Fa mice were measured by quantitative FACS analysis of cells stained 
with  fluorescein-conjugated  14-4-4  and  Y-17  monoclonal  antibodies.  The  14-4-4 
monoclonal antibody reacts with all Ia.7  + strains (20), and as shown in Fig. 2 a, c, and 
d, stains 55-70% of spleen cells from homozygous mice of k, d, and u haplotypes.  14- 
4-4 does not stain  B10.AOR  )  cells (Fig. 2b), which are Ia.7- and do not appear to 494  QUANTITATIVE  DEFICIENCY  IN  Ia  ANTIGEN  EXPRESSION 
TABLE  I 
Cytotoxicity  and Absorption Analyses of Y-17 Reactivity with Different AdE,  Complexes 
Strain 
Haplotype origin  Absorption 
of chains*  Cytotoxicity  analysis[[§  Conclusion 
Normalized num- 
ber of cells re-  Y- 17 reacts  50% titer 
Ae  E~  with Y-17:~§  quired to absorb  with Ae:E~ 
Y- 17 (B 10.A(5R)  complexes 
targets) 
(B6 ×  BALB/c)FI  b/d  d  104-10  s  ND¶  b:d 
B10.A(5R)  b  k  105  1.0, 1.0, 1.0, 1.0  b:k 
(B10 X A.TFR5)FI  b  k  104-105  1.2  b:k 
(BI0.A(5R) ×  BI0.T(6R))F~  b  k  104-105  1.6  b:k 
(B10 ×  B10.A)FI  b/k  k  104-105  1.2  b:k, k:k 
(B10 X B10.P)FI  b/p  p  104-105  ND  b:p 
(B10 ×  B10.PL)F1  b/u  u  0  7.3, 7.7  b:u 
(B10 ×  PL/J)FI  b/u  u  0  7.3, 8.2  b:u 
(BI0.A(4R) ×  BI0.D2)Ft  k/d  d  104  1.7  k:d 
BI0.A  k  k  10  a  1.0, 1.4, 1.3  k:k 
(B10.A(4R)  X B10.P)F~  k/p  p  104-105  3.3  k:p 
(BI0.A(4R) ×  B10.PL)FI  k/u  u  0  ND  (k:u)** 
(B10.S X B10.D2)FI  s/d  d  104-105  1.7, 3.0  s:d 
B 10.S(9R)  s  k  104-105  1.0, 1.3  s:k 
(BI0.S X B10.P)Fx  s/p  p  104  2.3  s:p 
(B10.S ×  BI0.PL)FI  s/u  u  0  7.7  s:u 
B10.PL  u  u  0  --:H: 
PL/J  u  u  0  -- 
B10.SM  v  v  10  ~  ND  v:v 
SM/J  v  v  105  ND  v:v 
* The haptotype origins of all `% and F~ chains synthesized are given. The synthesis of `% and E,, chains 
is variable, depending on the haplotype in the LA and I-E subregions, respectively, as follows (16,  17): 
d, k, p, r, u, v: synthesize both `% and E~ chains; b, s: synthesize `% but not E,, chains; f  q: synthesize 
neither ,% nor E, chains; ap5 (AtE k, strain A.TFRS): synthesizes E~ but not A~ chains. 
When both chains are synthesized (loci in cis or trans chromosomal position), `%:E, complexes are found 
on the cell surface. 
~: Reciprocal dilution of antibody giving 50% of maximal lysis. 
§Specificity  controls:  no  cytotoxicity  or  absorption  (with  62-125  ×  106  cells)  observed  with:  BI0 
(A~:--), A.TPR5  (--:E~, B10.P or BI0.F(13R)  (`%O:E~), B10.PL or PL/J  (A~:E,"), BI0.A(4R)  (A~ :--), 
B10.D2  (A~:E~), B10.S  (A~:--)  B10.S(8R)  (Ak°":--),  B10.T(6R)  (-----),  (B10.D2  X  A.TFR5)F~ 
(A~:E2'k). (B!O.D2 X B10.F(13R))F1  (`%d'D:E~P! (BI0.F(13R) x  A.TFR5)FI"(A~:E~'k), (B10.F(13R) X PL/ 
J)F1 (A~' :EP,  ' ), or (PL/J X A.TFR5)FI (`%:Eo'6). 
H  Number of spleen cells  (X106) required  to completely absorb Y-17  cytotoxic activity +  number of 
B10.A(5R)  spleen  cells  (X106) required  to  completely  absorb  Y-17.  Y-17  used  at  1:104 dilution. 
Denominator range -- 3 ×  106-5 ×  l0  s cells. 
¶ Not done. 
** Quantitative  immunofluorescence analysis  (Fig.  2,  Table  II)  will  show  that A~k:E~ complexes  are 
expressed,  but in low amounts. 
:H: No absorption with 187 X  l0  s cells (strain B10.PL); 61 X  106 cells for PL/J. 
synthesize or express an E. chain  (4). The  14-4-4 antibody  can detect A~:E~ complexes 
on  the surfaces  of cells  from  heterozygous  (4R  X  B10.D2)F1  and  (4R  ×  B10.PL)Fa 
mice;  however,  it  is  clear  from  the  FACS  curves  in  Fig.  2  that  the  positions  of the 
positive peaks  of 14-4-4 staining  in the F1 were shifted downward  by about  0.30  log 
units  relative  to  the  parental  strains  on  the  four-decade  log  scale  (compare  14-4-4 
staining in Fig. 2 e with 2 c  and  2 f and with 2 d). The  0.30 log unit difference between MeNICHOLAS  ET  AL.  495 
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NUMBER OF ABSORBING  CELLS (x 10  -6) 
FIo.  1.  Quantitative  absorption  analysis of Y-t7  on Bt0.A(5R)  spleen  celt  targets.  The strains 
used for absorption are indicated. Positive absorption controls: B10.A(5R)  (9)) (Ae:E~  and B10.A 
(A)  (A~:E~.  Negative  absorption  controls:  B10  (/1)  (A~:--)  and  (B10.D2  ×  B10.PL)FI  (O) 
b,u  u  (A~":F~"). Experimental:  (B10.S ×  BI0.PL)F]  (El)  (A~":E.")  and  (B10 ×  B10.PL)F]  (O) (Ae  :E.). 
~7, medium control, 
the means of the positive peaks corresponds approximately to a twofold difference in 
fluorescence intensity between the parental and F1 cells. 
The FACS curves from parental and Fa cells stained with the monoclonal antibody 
Y-17 are also presented in Fig. 2. No staining with Y-17 was observed on B10.A(4R), 
B 10.D2, and B 10.PL spleen cells, a result that confirms the cytotoxicity  and absorption 
data  presented  in  Table  I.  Y-17  did  stain  spleen  cells  from  F1  mice  expressing 
complexes formed by the association of A~ with E,  a  or E u chains; however, striking 
quantitative differences were detected in the cell surface expression of  A~:E~ complexes 
[(4R ×  B 10.D2)Fa, Fig. 2 e] compared to A~:E," complexes [(4R ×  B 10.PL)F1,  Fig. 2 f] 
as detected by the Y-17 antibody. The staining of (4R ×  B10.D2)F1  cells with Y-17 
was significantly brighter in fluorescence intensity (~0.45 log units) than the staining 
of (4R x  B 10.PL)F1 cells. Similar quantitative differences in intensity of Y-17 staining 
were also observed in indirect staining experiments. Using a  fluorescein-conjugated 
goat anti-mouse Fcv2  second-step antibody to detect Y- 17 binding (B 10.S ×  B 10.D2)Fx 
and  (B10  ×  B10.D2)Fa  cells  bound  considerably  more  Y-17  than  did  (B10.S  × 
B10.PL)F1 and (B10 ×  BI0.PL)Fx cells (data not shown). Despite the variable levels 
of Y-17  staining in the different mouse strains, the same proportions of spleen cells 
bound  14-4-4 and Y-17  in each strain; these proportions  (55-70%)  corresponded to 
the proportion orB cells, as determined by staining with fluorescein-conjugated rabbit 
anti-mouse Ig antibodies (data not shown). 
The use of the calibrated FACS-II for fluorescence analysis enabled us to quantitate 
directly the  number  of monoclonal anti-Ia  antibodies  bound  per  cell  (Table  II). 
Assuming that  most  antibody binding at  saturation  is monovalent  (27,  28),  these 
numbers reflect the numbers ofla molecules expressed per cell. The data from staining 
parental and Fa spleen cells with monoclonal anti-l-A antibodies (10-3.6,  anti-I-Ak; 
and MK-D6, anti-LA  d) are included to illustrate gene dosage effects in the expression 
of A~:A# complexes on parental and F1 spleen cells. As presented in Table II, 31,000- 
42,000 10-3.6 antibody molecules were bound per positive cell from B 10.BR mice and 
29,000-34,000  molecules were bound per positive cell from B10.A(4R)  mice, both 496  QUANTITATIVE DEFICIENCY IN  la  ANTIGEN EXPRESSION 
Fie.  2.  Immunofluorescence staining of parental  and  F1  spleen  cells  (a-f)  with  Y-17 (~), 
14-4-4  (  )  and control  (anti-dansyl)  monoclonal antibody 27-4-4 (---).  Cells  were  stained 
directly  with fluorescein-conjugated  antibodies and analyzed on a  FACS-II with a  logarithmic 
amplifier.  The FACS curves from cells stained with 27-4-4 and those curves from unstained cells 
(not shown) were identical (superimposed). Panel g shows a composite of the FACS curves from Y- 
17 stained cells from B10.BR (  ), (4R × B10.D2)FI (~),  (4R × B10.PL)F1 (- - -), and B10.PL 
( .... );  panel h  shows a  composite  of the FACS  curves  from  14-4-4 stained cells from  BI0.BR 
(  ), (4R ×  B10.D2)F~ (  ), (4R x  BI0.PL)F, (---), and BI0.A(4R)  ( .... ). 
I-A k  homozygotes,  whereas  approximately  half as  many  10-3.6  antibody molecules 
(19,000-21,000)  were bound to heterozygous  (4R  X  B10.D2)F1  (I-A k/a)  cells. Similar 
gene dosage effects were observed with d haplotype cells stained with MK-D6; B 10.D2 
(LA d homozygous) cells bound 32,000-42,000 molecules/cell while (4R X  B10.D2)F1 
cells bound  19,000-20,000  molecules/cell. The results in Table II also show that  the 
10-3.6 antibody, known to react with specificity Ia. 17 common to A~:Ap complexes of 
the k,f, s, and r haplotypes (21), also reacts with u haplotype cells, which had not been 
tested  previously for  Ia. 17 expression.  Thus  the  (4R  ×  B10.PL)Ft  (I-A k/u)  expresses 
homozygous levels of I-A molecules (30,000-33,000/ce11)  detectable by  10-3.6. McNICHOLAS ET AL.  497 
TABLE  II 
Levels of Ia Antigen Expression Determined by Quantitative Immunofluorescence 
Haplotype origin of 
chains*  Number of  antibody molecules bound (X lO-a):~ 
Anti-I-A  k  Anti-I-A  a  Anti-E,,  Anti-(A~:E~) 
A,  E~  10-3.6  MK-D6  14-4-4  Y- 17 
B10.BR  k  k  42.3  1.4  19.7  30.2 
31.4  1.4  16.8  22.2 
B 10.D2  d  d  <0.1  42.4  17.3  0.0 
0.2  32.4  15.4  0.3 
B10.PL  u  u  37.5  0.2  36.1  <0.1 
29.2  0.2  26.1  0.1 
B 10.A(4R)  k  --  34.1  0.9  0.1  0.2 
29.2  0.9  <0.1  <0.1 
(4R ×  B10.D2)F1  k/d  d  19.0  19.7  10.2  12.2 
20.8  19.5  8.7  11.1 
(4R × B10.PL)Fx  k/u  u  33.2  0.7  13.4  3.4 
30.1  0.7  11.8  3.3 
* The haplotype origins of all A~ and E~ chains synthesized  are given (see Table I). 
:]: The upper number of each pair corresponds  to the number of antibody molecules bound per cell in the 
experiment shown in Fig. 2. The lower numbers correspond  to results obtained in a duplicate experiment. 
The numbers of Ae:E~ molecules per cell as detected by  14-4-4 and Y-17 monoclonal 
antibodies were also calculated from the FACS curves shown in Fig. 2 and those from 
a  duplicate  experiment  (curves not shown).  For A~:E~ molecules, as noted  for A,:A~ 
molecules, gene dosage effects on expression were observed using  14-4-4 with parental 
and F1 cells. Homozygous Ia.7 + cells from B 10.BR,  B 10.D2, and B 10.PL stained with 
14-4-4  expressed  approximately  twice as  many  A~:E~  molecules per cell  as  did  cells 
stained  with  14-4-4  from  heterozygotes.  However,  gene  dosage  effects  alone  cannot 
rAk ,-,d  explain thc  quantitative  differences  bctwccn the  numbcrs ol  e:r~ complcxcs dctcctcd 
fA  k  ,-,u  by Y-17 on (4R ×  BI0.D2)FI cells  (ll,000-12,000/ccll)  and the numbcrs o  e:~ 
complcxcs dctcctcd by Y-17 on (4R ×  B I0.PL)FI cells  (3,300-3,400/ccii).  This 3.5- 
f  Ak  E d  A k E u  fold  difference  in the numbcr o ,~e: ~ complcxcs vs.  ~:  ~ complcxcs in the two Fa 
hybrids was confirmed in staining  cxpcrimcnts with a sccond monoclonal antibody, 
17-3-3, which appears to have spccificity  for the same A~:E~ complcxcs as thosc 
dcscribcd for Y-17 (29,  and our unpublishcd rcsuhs).  For all parcnt and FI mice in 
both cxpcrimcnts shown in Tablc II,  the numbcr of 17-3-3  molecules bound pcr cell 
was nearly idcntical  to  the  numbcr of  Y-  17  molcculcs  bound per  ccll  (data  not  shown). 
As with Y-17, the numbcl' of 17-3-3  molcculcs bound to (4R ×  BI0.D2)FI cclls 
(II,000-13,500) was thrcc to four times thc number of 17-3-3 antibodies bound to 
(4R × BI0.PL)FI cclls  (3,100-3,900). 
Thc sevcn- to cightfold  reduction in expression ofAk:E~ complcxcs in FI hybrids 
Ae:E~ complcxcs in homozygous  BI0.BR cclls,  as  comparcd to the cxprcssion of  k  k 
dctcctcd by Y-17 staining,  is  in  good agreement with thc  comparativc valucs  obtained 
from quantitative  absorption  experiments  for A~ :E~  and  A~ :E~  complexes  (Table 498  QUANTITATIVE DEFICIENCY  IN  Ia ANTIGEN EXPRESSION 
I). Seven to eight times more (b  X  u)F1 or (s  X  u)F1 cells were required to absorb all 
Y- 17  activity compared to  homozygous B 10.A(5R)  (I-A b,  I_E  k)  or B 10.S(9R)  (I-A 8, 
I-E k)  cells. Thus  two  independent  quantitative  methods  of analysis revealed unex- 
pectedly low levels of expression of Ia complexes comprised of  E~ chains and A, chains 
of the b, k, and s haplotypes in F1 hybrids. 
The  serological approaches  described above  have  shown  clearly the  quantitative 
•  •  b,k,s  u  deficiency in expression m Ae  :E~ complexes on the surfaces of cells from appropriate 
heterozygotes. However, these methods provide no information on the molecular basis 
for this phenomenon. The results of 2-D PAGE analyses presented in the next section 
suggest that the low levels  rAbka "r~u  OtAe' ' :r_,~ complexes expressed on F: cells may be due to 
the preferential associated of E~ chains with A~ chains. 
Predominant  Association  of E~ Chains with A ~ Chains  over A ~,k,s Chains  in F1 Hybrids.  2-D 
PAGE of immunoprecipitated A~:E~ complexes  from  heterozygotes clearly show  an 
excess  of E~  chains  associated  with  A~  chains  compared  with  A~  chains  of other 
parental haplotypes. This finding was observed initially in gels of anti-I-E immuno- 
Fro.  3.  (A~:E~) complexes  are  present  in  lower  amounts  than  (A~:E~) complexes  in  (4R  X 
B10.PL)FI cells: comparison with  (4R  ×  Bi0.P)FI. Extracts  from [a~S]methionine-labeled  spleen 
cells were immunoprecipitated  with  normal  mouse serum  (a-d) or [(BI0.S(TR) ×  A.CA]F1 anti- 
BI0.HTT  (anti-I-E)  antiserum.  The  panels  show portions  of fluorograms  of 2-D  gels of the 
immunoprecipitated  proteins. Panels a, b, e, and f represent the immunoprecipitates  from 4 ×  106 
cells. Panels c, d, g, and h  represent  the immunoprecipitates  from 8 X  l0  s cells. Fluorographic 
exposure of the gels was for 7 d. The position of actin (43,000 mol wt) is indicated by the letter a in 
panel a. Confirmatory results were obtained in a second experiment. McNICHOLAS ET AL.  499 
precipitates from  (4R  ×  B10.PL)Fa heterozygotes. As shown in  Figure 3h,  there is 
considerably less A~ chain than A~ chain in this immunoprecipitate. In contrast, (4R 
×  B10.P)Fa,  a  control  heterozygote, has  very balanced  proportions  of A~  and Ag 
chains (Fig. 3 g). 
A second approach to demonstrating biochemically the quantitative differences in 
A~ and  A~ chains in  heterozygotes is  through the use of the monoclonal antibody, 
Y-17. Fig. 4 shows immunoprecipitates prepared with Y-17 and the anti-Ia. 7 mono- 
clonal antibody  14-4-4  from (4R  ×  B10.PL)Fx and the control heterozygote (4R  × 
BIO.D2)Fx, as well as from homozygous k, d, and u haplotype strains. From the 14-4-4 
precipitates  it  again  appears  that  A~  chains  outnumber A~  chains  in  the  (4R  × 
B10.PL)F1 cells  (Fig.  4j),  whereas A~  and A~  chains are present  in  more balanced 
proportions in (4R ×  B10.D2)F1 cells (Fig.  4i). Since Y-17 does not react withA~:E~ 
k,  u  k  d  or A~:E  d molecules, it immunoprecipitates only the Ae.E~ and Ae:E~ complexes from 
the two heterozygotes. Comparing the intensities of the gel patterns in Fig. 4n with 
40 confirms the abnormally low levels of complexes containingA~  k  chains in  (4R  × 
B10.PL)Fa  cells.  Only  a  small  proportion  of the  total E~  chains  precipitable  by 
14-4-4  appears  to  be  associated  with  the A~  k  chains  (compare Fig.  4j  with  4o),  in 
contrast to the considerable proportion ofE  d chains associated withA~  k chains in (4R 
×  B 10.D2)F1  cells (compare Figs. 4 i and 4 n). 
Fxo. 4.  (A~:E~) complexes are  present in  lower amounts than  (A~:E~) complexes in  (4R  X 
B10.PL)FI cells: comparison with (4 x  B10.D2)FI. [SSS]methionine-labeled  Ia antigens were im- 
munoprecipitated with supernatant fluid from hybridomas producing the following  monoclonal 
antibodies: a-e, 10-4.22, (control,  anti-lg-5a heavy  chain); f-j, 14-4-4 (anti-Ia.7);  k-o, Y-17 (anti-Ae: 
F~), see text). All panels represent immunoprecipitates  from 4 ×  106 cells. Fluorographic  exposure 
of the gels was for 7 d. 500  QUANTITATIVE  DEFICIENCY  IN  Ia  ANTIGEN  EXPRESSION 
Fro.  5.  (A~:E~) complexes  are  present  in  lower  amounts  than  (A~:E~) complexes  in  (BI0  x 
B10.PL)F~  cells:  comparison  with  (B6  ×  BALB/c)F1.  [aSS]methionine-labeled la  antigens  were 
precipitated with normal mouse serum (a, d, g,j); [B10.S(7R)  ×  A.CA]FI anti-B10.HTT  (anti-I-E) 
antiserum (b, e, h, k); or Y-17 ascites (anti-(Ae:E~))  (c, f, i, 1). All panels represent immunoprecipitates 
from  4  ×  10  s  cells.  Fluorographic  exposure of the  gels was  for 6  d.  Confirmatory results  were 
obtained in a second experiment. McNICHOLAS  ET  AL.  501 
Similar findings have been obtained forAY:El complexes in (B 10 X B 10.PL)FI cells. 
Figure 5 k shows the preponderance of  A~  chains over A b chains in anti-I-E immu- 
noprecipitates from this heterozygote, and the low levels ofAb:E  u chain complexes are 
clearly revealed by the faintness of  A~ and E~ spots from the Y- 17 immunoprecipitate 
(Fig. 5 l). In contrast, significantly higher amounts ofA  b chains are able to associate 
with E d chains in (B6 X BALB/c)F1 cells, as indicated by the gels from both the anti- 
I-E (Fig. 5 h) and Y-17 (Fig. 5 i) immunoprecipitates. Analogous results were observed 
AS.E  u  in two cxpcrimcnts for  ..... complexes (data not shown). In summary, biochcmical 
analyses of  Ae:E~ molecules from u-haplotype hctcrozygotes have indicated that the 
E~ chains present in cells  from these mice are associated predominantly  with A ue 
chains and only to a small cxtcnt with  Ae  b'k's chains. 
Discussion 
These studies were initiated in an attempt to explain, at the molecular level, the 
basis for the unique failure of the u haplotype among all other Ia.7 ÷ haplotypes to 
provide an I-E subregion capable of interacting with 1-.4' or/-.4 s to allow a response 
to the antigen pigeon cytochrome c. As is shown in the accompanying paper (19), F1 
hybrids between B 10.A(4R) (1-.4") or B 10.S (1-.4 ~) and strains bearing I-E a'ke'r are all 
able to respond to this antigen; the Ir genes controlling this response, which map to 
the 1-.4 and I-E subregions, appear to act in the APC  (30). Our previous studies  (4, 
13, 26)  have suggested that the A~ and E, Ia polypeptide chains are the product of 
these Ir genes,  and  that  expression of appropriate A~:E, complexes is  required for 
responsiveness. Therefore, it seemed likely that  the failure of the Ia.7  + u haplotype 
(strain  B10.PL)  to  complement  B10.A(4R)  or  B10.S  for responsiveness  to  pigeon 
cytochrome c resulted from the failure of heterozygous cells to express A~:E,  ~ com- 
plexes that are qualitatively and/or quantitatively normal. 
Our approach to this problem has been to examine a series ofF1 hybrids serologically 
and biochemically for the expression of A~:E~ complexes. Using Y-17, a monoclonal 
antibody that  reacts with  specificity Ia.m44  found on Ab'k'~:E~ complexes but  not 
parental A~:E~ complexes, we found in quantitative absorption and immunofluores- 
bks E u  cence studies  that A~' ':  ~ complexes are indeed expressed on the surfaces of cells 
from appropriate heterozygotes but that they are present at one-fourth to one-eighth 
of the  expected amount.  2-D  PAGE analysis of Ia  immunoprecipitates  revealed a 
A u E"  r A b  k  s  ,',u  marked prcdominancc ol  e:  ~ complcxes ovc  e' ':r~ complexes in thc cells. 
This dramatic imbalance in the relative  amounts of thc two combinations of A~ 
and E~  chains could be  duc to  eithcr  a lower  level  of  synthesis  ofA  b'k'~  chains compared 
with A~ chains or a prcfcrcntial  association  of  E~ chains with A~ chains comparcd 
with A~  'k'~  chains.  To distinguish  bctwccn thcsc  possibilities,  the intensities  of  A~ spots 
on  autoradiograms  of total lymphocyte  proteins separated  on  2-D  PAGE  wcre 
examined. In gels  of (4R X  BI0.PL)Fx extracts,  thcA  k  n  "  a  d A~ Spots  had about the 
samc intensity,  similar  to  the  intcnsities  ofA  k andA~  d spots  from a control hetcrozygotc 
(4R X B 10.D2)Fa (P.  Jones, unpublished results).  Similar results  were obtained with 
thatA~' '  chain synthesis  (b X  u)F1 and (s ×  u)F1 heterozygotes. These results suggest  bks 
is normal in u-haplotype heterozygotes and that the low level of expression of these 
chains is probably due to the preferential formation of A~:E~  complexes. The small 
amounts  of A~  'k~ :E~  complexes expressed  apparently  are  not  sufficient  to  allow 
immune responses to the antigen pigeon cytochrome c. 502  QUANTITATIVE DEFICIENCY IN Ia ANTIGEN EXPRESSION 
The quantitative variability in Ia antigen expression shown by these studies thus 
represents an additional source of Ia heterogeneity with potential effects on immune 
responsiveness.  The  dramatic  difference  in  representation  of A u'vu~.~,  and  Ab'k's'E  ue  •  ,~ 
complexes  in  u-haplotype  heterozygotes  represents  an  extreme  example  of such 
quantitative variability. However, the immunofluorescence data presented in Table 
II  indicate  that  smaller  differences also  exist  between  /-region  homozygotes and 
heterozygotes. As shown by the binding of monoclonal anti-I-A and anti-I-E (speci- 
ficity Ia.7) antibodies, I region heterozygotes express approximately half as much A~: 
A#  and  A,:E,  complexes as  do  the  parental  homozygous strains.  The  finding  of 
reduced Ia.7  expression on  the  (4R  X  B10.D2)F1  and  (4R  x  B10.PL)F cells  is  of 
particular interest. These F1 hybrids have only one copy of the gene for an expressed 
E~ chain; I-E b from B10.A(4R) carries a null allele for the E~ chain (4,  16). Because 
cells from both heterozygotes express approximately half as much Ia. 7 as the parental 
BI0.D2 and B10.PL ceils, they apparently do not compensate for the presence of only 
one active E~ gene by increasing the amount of E, chains synthesized from that one 
gene. Analogous gene dosage effects on Ia.7 expression were also observed with (B10.S 
X B10.D2)Fx and (B10.S ×  B10.PL)F1 ceils relative to B10.HTT (I-A s, I-E k) cells and 
with (B 10 ×  B 10.D2)F1 and (B 10 X B 10.PL)F1 cells relative to B 10.A(5R) (LA b, I-E k) 
cells (J. McNicholas and P. Jones, unpublished observations). These variations in Ae: 
E~ complex expression may be involved in previously described gene dosage effects on 
immune responsiveness to antigens under a-fl lr gene control (36, 37). 
The  quantitative  immunofluorescence data  in  Table  II  reveal  additional  unex- 
pected features of Ao:E~ expression.  First,  Y-17  seems  to  react  with  more sites  on 
B10.BR  cells  than  does  14-4-4,  a  surprising  result  if these  two  antibodies  simply 
recognize different sites on the same Aek:E  k complex. Staining levels similar to those 
obtained with Y-17 also were obtained with the monoclonal antibody 17-3-3, which 
appears to recognize the same or a very similar determinant as Y-17 (29). The reason 
for the lower degree of staining of B10.BR cells by 14-4-4 is not clear; perhaps some 
of the E k chains expressed on the cell surface are oriented in such a way that the Ia.7 
specificity recognized by 14-4-4 is not exposed. Suggestive evidence for the absence of 
Ia.7 determinants on some Ia.m44  ÷ molecules has come from sequential immunopre- 
cipitation  studies.  The  anti-I-E  antiserum  (B10.S(7R)  ×  A.CA)F1  anti-B10.HTT 
failed to clear all Ae:E~ complexes recognized by Y-17, as determined by 2-D PAGE 
(P. Jones, unpublished observation). 
A second rather surprising finding concerns the level of staining, somewhat higher 
than  anticipated,  of (4R  ×  B10.D2)F1  ceils  with  Y-17.  The  14-4-4  staining  data 
indicate that there are approximately half as many E~ (Ia.7) determinants on this FI 
as on homozygous B10.BR and  B10.D2 cells, consistent with there being only one 
copy of the gene for an expressed E~ chain. Of the A~:E~ complexes expressed by the 
Ae:E, but not the Ae:E~ complexes should express Ia.m44.  (4R ×  B10.D2)Fi cells, the  k  d  d  a 
If these two forms of A~:E~ complexes were expressed in equal amounts, Ia.m44 should 
have been  expressed on  (4R  x  B10.D2)F1  cells  at  a  level one-fourth that  on  the 
homozygous B 10.BR cells.  Instead, however, the F1 cells express one-half to one-third 
as many Ia.m44 determinants as B10.BR. One explanation for this result might be 
of Ae:E~  than  complexes. Alter-  that  Ia.m44 is exposed on a  greater fraction  k  d  Ae:E~k  k 
natively, this  finding could reflect preferential chain  association analogous  to that 
observed with u haplotype chains. IfAk:E  d complexes formed preferentially compared McNICHOLAS ET AL.  503 
to A~:E  d complexes, the level of staining with Y-17  would not simply reflect gene 
dosage effects. 
An important concept that has emerged from recent studies of Ia structure and 
function is the significant role of combinatorial association of Ia polypeptide chains 
in the generation of Ia molecular polymorphism. Biochemical studies have revealed 
the presence of mixed haplotype (hybrid) A~:E~ (4, 16, 38) and A~:At~ (18) complexes 
on cells from I region heterozygotes. These findings provided a molecular explanation 
for lr gene complementation. However, the simple formation of complexes of specific 
tact  and fl chains is  not  in  itself sufficient to  explain  Ir  gene complementation; 
responder F1 Ia complexes formed from a and fl chains derived from two nonresponder 
parental haplotypes must provide unique structural determinants not expressed by 
parental Ia molecules. Therefore, T  cells involved in the responses to antigens under 
dual lr gene control must recognize small regions of Ia complexes unique to particular 
combinations of a  and fl chains. These regions probably include combinatorial sites 
at junctions  between  the  two  chains  as  well  as  conformational  determinants  in 
individual  chains  that  require  certain  allelic  forms of the  second  chain  for  their 
expression. 
Considerable serological evidence for the existence of unique antigenic determinants 
on certain A~:E~ complex has emerged recently. Four distinct determinants of this 
type have been defined: Ia.m44 recognized by the Y-17  (13) and  17-3-3 (29) mono- 
clonal antibodies, Ia.m47 defined by the A303  monoclonal antibody developed by 
Harris and Delovitch (39),  and Ia.22 and Ia.23 recognized by standard alloantisera 
(40,  41).  It is clear that T  cells are also able to recognize unique combinatorial or 
conformational  determinants  (13,  42-45).  As  discussed  above,  the  generation  of 
combinatorial polymorphism through a and fl chain joining is critical to the formation 
of Ia molecules with a wide range of immune response phenotypes. The localization 
of some of the genetic polymorphisms of Ia antigen polypeptide chains in  regions 
involved in the joining of the two chains may in fact increase the contribution of 
primary structural polymorphism to Ia antigen diversity. If  junctional regions of Ae 
and E, chains do tend to vary structurally among haplotypes, occasional effects on 
the ability of chains from different haplotypes to associate might well be anticipated. 
The  skewed  proportions  of different  Ae:E~  complexes  on  cells  from  u-haplotype 
heterozygotes might  simply  be  a  consequence  of the  location  and  nature  of the 
polymorphism of the A~ and/or E~ chains. 
The  finding of imbalanced representations of different A~:E~ complexes in cells 
from I region heterozygotes has significant implications for investigations of analogues 
of Ia  antigens  and  Ir  genes  in  other  species.  The  inability to  predict  Ia  antigen 
phenotype on the basis of MHC genotype alone may hamper efforts to establish Ia 
structure-function relationships in species not as well-defined genetically as the mouse. 
In particular, variability among individuals in the levels of expression of certain HLA- 
DR antigens might contribute to the difficulty in establishing associations between 
HLA-D  and certain disease states in humans. 
Summary 
These studies were stimulated by the observation, reported in the accompanying 
paper (19), that 1-E u failed to interact with 1-A ~ or I-.4 8 in F1 mice to allow a response 
to the antigen, pigeon cytochrome c, unlike I-E subregions derived from other Ia.7  + 504  QUANTITATIVE DEFICIENCY IN Ia ANTIGEN  EXPRESSION 
haplotypes.  Serological  and  biochemical  analyses  were  performed  to  determine 
k,a  whether  or not  cells  from these  F1  mice express  the Ae  :E~  complexes  that  should 
function  as  restriction  elements  for T  cell  recognition  of pigeon  cytochrome c  on 
antigen-presenting  cells.  Using the Y-17 monoclonal antibody, which recognizes the 
combinatorial or conformational determinant Ia.m44 on certain A~:E~ complexes, we 
Ae.E~  and  ~  .  ~  complexes  on  cell  surfaces.  were  able  to  distinguish  between  u.  u  Ab,k,a.E  u 
Although  complement-dependent  microcytotoxicity  with  Y-17  failed  to  detect 
bk,a  u  A~'  :E~ complexes on cells from appropriate  F1 mice, these molecules were detected 
by both quantitative absorption and quantitative immunofluorescence studies.  How- 
ever, A~'k'8:E~ complexes were found to be present  at levels only one-seventh to one- 
eighth the levels expressed by homozygous I-A b, i.Ek; I.A k, i.Ek; and I-A s, I-E k cells. 
The  results  of two-dimensional  polyacrylamide  gel electrophoresis  analyses  suggest 
that  the  low  levels  of expression  of A~'k'S:E  u  complexes  are  a  consequence  of the 
preferential  association of A~ and E~ chains with each other in the Fa cells. As will be 
shown  in  the  following paper  (19),  the  quantitative  deficiency in  the  expression  of 
A~:E~ and  Ag:E~ complexes results  in  a  corresponding defect  in  antigen-presenting 
cell function, thus providing strong evidence that Ia antigens represent products of lr 
genes. 
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